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Introduction: primary Raynaud's disease may be difficult to differentiate clinically from the secondary form with an
underlying connective tissue, haematological, neurovascular or drug-induced disorder. We undertook a study to determine
the elastic carotid and muscular femoral arterial biomechanical properties and intima-media thickness (IMT) in subjects
with primary and secondary Raynaud's disease, to assess whether these parameters could differentiate the two conditions.
Methods: twenty patients with primary Raynaud's disease and 53 subjects with secondary Raynaud's associated with
scleroderma (systemic sclerosis, SSc) had measurements of their carotid and femoral wall mechanics with a duplex scanner
coupled to a Wall Track system. Their age, gender, body mass index, heart rate, systolic and diastolic blood pressures,
presumed cardiovascular load, plasma creatinine, fasting cholesterol, triglyceride and glucose concentrations were also
measured.
Results: the carotid elastic properties [mean (SD): elastic modulus: 560 (180) vs 1204 (558) mmHg, p5 0.001 and
stiffness index: 5.69 (1.35) vs 11.92 (6.4), p5 0.001 for primary and secondary Raynaud's respectively] were significantly
impaired in patients with secondary Raynaud's disease even after adjustment for potentially influencing physiological and
biochemical variables. There were no statistical differences in the femoral elastic properties or the carotid and femoral IMTs
between the two groups.
Conclusion: Duplex determination of the carotid elasticity or stiffness is different in primary Raynaud's phenomenon
compared with secondary Raynaud's associated with SSc. This may be a useful non-invasive tool, in addition to auto-
antibody markers and nail-fold capillaroscopy, to differentiate between the two forms of Raynaud's phenomenon.
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Introduction
Raynaud's syndrome was first described in 1862 by
the French physician, Maurice Raynaud. It is charac-
terized by spasm of the small arteries of the fingers
and toes, causing the skin to turn pale and dusky blue.
Estimates of its prevalence range from 5 to 30% of the
population. It is five times commoner in women, par-
ticularly between the ages of 18 and 30 years. It is
thought that 25±30% of cases occur in healthy women.
Primary Raynaud's disease has no known cause.
However, a multi-centre observation study has
shown that 48% of primary Raynaud's showed one
or more clinical features, indicating a high risk of
evolving into scleroderma (systemic sclerosis, SSc).1
Secondary Raynaud's is associated with an underly-
ing connective tissue, neurovascular, haematological
or drug-induced disorder. The same study has shown
that secondary Raynaud's was most frequently asso-
ciated with SSc and was often the first presenting
symptom of SSc, often preceding the connective tissue
disorder by months to years.1
It is sometimes difficult to distinguish primary
Raynaud's disease from the secondary form. Nailfold
capillaroscopy may be able to diagnose Raynaud's
secondary to SSc. As SSc is a generalized connective
tissue disease affecting other organs of the body apart
from the skin, we may expect to see changes in the
connective tissue matrix and hence, the wall mechan-
ics of large arteries. There has been no study we could
find in the literature looking at the carotid and femoral
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wall mechanics in primary and secondary Raynaud's
disease.
The aim of this study is to determine the elastic
carotid and muscular femoral biomechanical proper-
ties and intima-media thickness (IMT) in subjects with
primary and secondary Raynaud's disease to assess
whether we could use these parameters to differenti-
ate the two forms.
Methods
Elastic indices
The arterial biomechanical properties are well
described.2±5 In this study, we use the diametrical
compliance (C), Petersen's elastic modulus (Ep) and
stiffness index (b) to assess the common carotid and
femoral wall mechanics to avoid bias towards any of
the parameters. Both C and Ep are dependent on
blood pressure but b is claimed by some authors to
be less pressure dependent.6
Subjects
A total of 73 subjects were recruited prospectively in
this study, which has been approved by the local
hospital Ethics Committee and conformed to the
principles of the Declaration of Helsinki. Twenty had
primary Raynaud's disease and 53 had thermograph-
ically confirmed secondary Raynaud's disease asso-
ciated with SSc.
Raynaud's disease was diagnosed by the classical
colour changes, which occurred in the digits of the
hands or/and feet. Primary Raynaud's was defined
by the Allen and Brown's criteria of negative nail-fold
capillaroscopy and normal serological study (sera
screened on Hep 2 cells at 1:100). SSc was diagnosed
clinically by an experienced rheumatologist and
broadly followed the classification criteria of the
American College of Rheumatology. Ninety-five
percentage of cases carried antinuclear antibodies
and in 70% these included a hallmark SSc associated
reactivity. Patients were recruited consecutively from
the rheumatology and general surgical clinics. No
other exclusion criteria were applied.
Measurements
The age, gender, body mass index (BMI), heart rate,
systolic and diastolic blood pressures were recorded
for all subjects. In addition, the plasma creatinine,
fasting cholesterol, triglyceride and glucose were
measured.
The presumed cardiovascular load assessed on the
basis of a cumulative total vascular risk score (TVRS)
was calculated for all subjects.5,7 This was based on
Lehmann's study, which showed a significant inverse
relation between the aortic compliance and the num-
ber of cardiovascular risk factors.7 We believed that
this was a significant finding and has modified the
TVRS to include hypercholesterolaemia, peripheral
vascular disease and renal impairment.5 These risk
factors and events were as follows: (1) current cigar-
ette smoking or ex-smoker within the last 12 months;
(2) history of hypertension on medication; (3) history
of hypercholesterolaemia on medication; (4) history
of diabetes mellitus; (5) history of ischaemic heart
disease; (6) history of stroke, transient ischaemic
attack or known carotid stenosis 450%; (7) known
renal impairment and (8) peripheral vascular disease.
Although we have not formally assessed the modified
scoring system, we believed that this is one method,
which allowed equal adjustment of the cardiovascular
load in our groups of subjects.
The subjects were rested for 10 min in the supine
position to allow resting pulse rate and blood pressure
to be achieved before any form of measurement was
performed. Heart rate and blood pressure were
recorded non-invasively from the right brachial artery
using an automated pressure monitor (Dynamap
Compact TS, Johnson & Johnson Medical, Newport,
U.K.). Real-time B-mode and M-mode images of the
arterial wall motion and IMT were recorded using a
7.5 MHz linear array probe in the sagittal plane at 90
to the long axis of the artery using a specially adapted
duplex scanning system (Pie 350, Pie Medical
Systems, Maastricht, The Netherlands) with signal
output to a high-resolution, echo-locked Wall Track
system (Wall Track, Pie Medical Systems, Maastricht,
The Netherlands).5,8±11 This system tracked the
anterior and posterior walls of the vessel over a
cardiac cycle. Each recording was programmed to
last for 2 s in order to catch at least one R wave-trigger
reading and also not to distort the results by
prolonged tracking of the specific part of the vessel.
It also automatically measured the far wall IMT of the
vessel. The far wall was chosen because it has been
shown to be more accurate than the near wall IMT.12,13
The IMT was recognized by the double line pattern
corresponding to the lumen-intima and media adven-
titia interfaces.12 The distance between these two
interfaces is the IMT.12,14,15
The side of the recording was chosen such that it
was the asymptomatic side or the side with the lowest
degree of stenosis. The site was chosen such that no
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visible atheroma could be visualized on the duplex
scanner. Measurements were taken within 3 cm
proximal to the bifurcation of the common carotid or
common femoral artery. Vessel wall motion and IMT
were each recorded for three times from the common
carotid and common femoral arteries. The average of
three recordings of the vessel distension was taken as
the mean diastolic and systolic luminal diameters. The
average of three IMT recordings was used as the mean
IMT. The elastic indices were subsequently calculated
from the given equations.5
Data analysis and statistical methods
The chi-squared test was used to compare the gender
ratio between the two groups. The remaining physio-
logical and biochemical variables were compared
between the two groups using unpaired (independ-
ent) t-test. A general linear model was applied to
estimate differences in means in the carotid and fem-
oral elastic indices and IMT between the two groups
of subjects, after adjusting for potentially influential
variables, including age, BMI, heart rate, systolic and
diastolic pressures, TVRS, plasma creatinine, fasting
cholesterol, triglyceride and glucose concentrations.
The intra-observer variations were quantified from




where Vb is the between subject variance and Vw is the
within subject variance.
The inter-observer errors in our unit has been
determined from our previous study with the ICCs
between 0.88 and 0.91 for carotid and femoral
distensions and 0.89 for carotid and femoral IMT
measurements.5
All statistical tests were performed with SPSS
version 10.05 for Windows.
Results
The physiological and biochemical parameters
between primary and secondary Raynaud's are
shown in Table 1. Patients with secondary Raynaud's
were significantly older and had significantly higher
heart rate and systolic blood pressure than those with
primary Raynaud's. Both primary and secondary
Raynaud's were commoner in female subjects.
Patients with secondary Raynaud's disease caused
by SSc have significantly impaired carotid elastic
properties [mean (SD): C: 9.5 (3.01) vs 19.54 (5.71)
% mmHgÿ1 10ÿ2, p5 0.001; Ep: 1204 (558) vs 560
(180) mmHg; b: 11.92 (6.4) vs 5.69 (1.35) for secondary
and primary Raynaud's respectively] (Table 2). This
highly significant finding exists even after adjustment
for potentially influencing physiological and biochem-
ical variables (Table 3). There are no statistical differ-
ences in terms of the femoral elastic indices, the
carotid and the femoral IMTs between the two groups
(Table 3).
Table 1. Physiological and biochemical parameters between pri-








Age (years) 42.75 (15.58) 55.43 (11.35) <0.001
BMI (kg/m2) 23.65 (3.35) 23.82 (3.71) 0.85
Heart rate
(beats/min)
79.60 (6.60) 83.51 (7.83) 0.04
Systolic BP
(mmHg)
119.50 (15.60) 139.58 (17.7) <0.001
Diastolic BP
(mmHg)
78.15 (12.86) 76.7 (11.38) 0.64
TVRS (number) 0.35 (0.75) 0.57 (0.8) 0.3
Creatinine
(mmol/l)
71.00 (10.86) 93.83 (59.27) 0.11
Cholesterol
(mmol/l)
4.77 (1.26) 5.01 (1.02) 0.55
Triglyceride
(mmol/l)
1.89 (1.02) 1.78 (0.79) 0.73
Glucose
(mmol/l)
5.02 (2.62) 4.87 (1.83) 0.81
Data are mean (SD). M denotes male and F denotes female. BMI is
the body mass index. TVRS is the total vascular risk score.









19.54 (5.71) 9.50 (3.01) <0.001
Carotid Ep
(mmHg)
559.50 (180.56) 1204.07 (558.23) <0.001
Carotid b
(dimensionless)
5.69 (1.35) 11.92 (6.4) <0.001
Femoral C
(% mmHg 10ÿ2)
6.35 (4.29) 5.55 (3.93) 0.49
Femoral Ep
(mmHg)
2095.36 (993.82) 2549.17 (1386.89) 0.23
Femoral b
(dimensionless)
21.34 (9.85) 24.38 (13.21) 0.4
Carotid IMT
(mm)
0.63 (0.19) 0.65 (0.24) 0.74
Femoral IMT
(mm)
0.64 (0.19) 0.74 (0.31) 0.2
Data in mean (SD). C denotes diametrical compliance, Ep the
Petersen's elastic modulus and b is the stiffness index.
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The intra-observer ICCs for the carotid and femoral
distension and IMT measurements varied from 0.92 to
0.96, indicating a high level of reproducibility.
Discussion
The theoretical accuracy of the Wall-Track system is in
the region of three microns for distension and ten
microns for arterial diameter.16 The reproducibility of
the duplex-Wall Track system is good with errors of
between 8 and 12% for the carotid compliance17±20 and
well below 20% for the IMT.21±25 Our study has shown
intra-observer errors of no more than 8%.
The blood pressure should ideally be measured
from the same segment of artery under investigation.
However, the brachial pressure is used because it is
more accessible than either the carotid or femoral
artery and it has been used as the reference point in
many published research.26±31 The validity of this
approach has also been verified by several groups.32±35
The problem associated with this method of measure-
ment of blood pressure arises in the young or healthy
patients because the pulse pressure increases by around
18±31% between the aorta and the brachial artery.36,37
This is caused by reflected waves from the periphery
leading to augmentation of the peak pressure wave in
the peripheral arteries close to the reflection sites.38,39
However, with increasing age the pulse wave velocity
increases so that the augmentation phenomenon also
occurs in the central arteries.40,41 Thus the differences
in the pulse pressure between central and peripheral
arteries disappear in the middle-aged and elderly
subjects.38 Since our subjects were on the whole in the
middle ages, we could therefore assume that the brachial
pressure reflected the carotid and femoral pressures.
There is the first study we know of the effects of
Raynaud's disease on the carotid and femoral wall
elastic properties and IMT. Secondary Raynaud's dis-
ease with underlying SSc is significantly associated
with increased carotid stiffness and elasticity or
reduced carotid compliance. This impaired carotid bio-
mechanical behaviour may be the result of altered
fibrillin-1 metabolism. It may be relevant that
fibrillin-1 (FBN-1) metabolism has been reported to
be altered in SSc fibroblasts cultured from non-
involved sites.42 Defective fibrillin function leads to
aortic abnormalities in humans with Marfan syn-
drome and in a haplo-insufficiency mouse model.43,44
Abnormalities in uninvolved skin fibroblasts are con-
sistent with a genetically based alteration in fibrillin
biochemisty in SSc. Another explanation is the result of
increased vascular tone secondary to repeated reperfu-
sion injury associated with the severe form of digital
vasospasm seen in secondary Raynaud's. The last
explanation may be due to increased cardiovascular
load in subjects with secondary Raynaud's. The carotid
elastic properties are recognized as good markers of
cardiovascular risk and events.3,4 Indeed, subjects with
secondary Raynaud's caused by SSc have higher risk of
hypertensive crisis and pulmonary hypertension.
The femoral artery is not similarly affected because
it is a muscular rather than an elastic artery. It is
interesting that fibrillin-1 regulates elastin fibre
assembly and elastin is expressed most commonly in
the elastic arteries.45,46
Ultrasonic measurement of the carotid elastic
properties is an invaluable clinical tool in
the assessment of Raynaud's disease and provides
further complementary information in addition to
tests such as antinuclear antibodies and nail-fold
capillary microscopy.47 This method is non-invasive,
accurate and reproducible. It is quick and easy to
perform by a trained vascular technician with the
available hardware and software and should be read-
ily available in a vascular unit with easily accessible
vascular laboratory.
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